Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Walter Koroshetz, director of the National Institute of Neurological Disorders and ...

ROCHESTER — By all appearances, sociologist Michael Bronstein's research grant is active. In March, the National Institutes of Health grant — which sponsors his team's research on COVID-19 vaccine ...

The NIH has been transformed this year. And most of the layoffs, policy changes, and politically motivated funding cuts—notably, to infectious-disease research—have happened under Bhattacharya’s watch ...

WASHINGTON, Dec 17 (Reuters) - The U.S. National Institutes of Health is seeking to fill nearly half of its top roles at breakneck speed following a wave of departures since President Donald Trump's ...

Fred D. Ledley's research has been supported by grants to Bentley University from the Institute for New Economic Thinking, National Pharmaceutical Council, West Health, and the National Biomedical ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Signaling a move toward the next phase of change, leaders at the ...

A warehouse worker consumed 8 energy drinks a day to "stay alert" at work, which led to a dangerous health condition Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared ...

The National Institutes of Health longstanding "payline" has helped everyone see the connection between the scientific peer review process and NIH grant funding decisions. What will the latest NIH ...

In 2025, more than 3,800 research grants from the National Institutes of Health and the National Science Foundation were terminated or frozen as part of the Trump administration’s effort to realign ...

NEW YORK (AP) — Over 74,000 people enrolled in experiments have been affected by the National Institutes of Health’s funding cuts, according to a new report. Between the end of February and mid-August ...

RESEARCH TRIANGLE, N.C., Oct. 22, 2025 /PRNewswire/ -- Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing the first reversible thrombolytic therapy for acute ischemic ...